Gary S. Guthart
Known title: President & CEOCIK: 0001280628
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Illumina Launches BioInsight Platform Amid AI Drug Discovery Trends. Illumina introduced its BioInsight Platform, a new unified software environment designed to speed up genomic and multiomic research. This move aligns with broader industry trends, including the recent $150 million IPO of AI drug discovery firm Iambic. Analysts are currently evaluating whether the stock's current valuation reflects these strategic shifts in AI and diagnostics.
Transaction History
| ISRG | ▼ Sell | Open Market | 10,000 | $4.0M | 8/11/2026 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,506 | $0 | 2/28/2026 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,243 | $626K | 2/28/2026 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 26,334 | $0 | 2/28/2026 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 13,059 | $6.6M | 2/28/2026 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 4,960 | $0 | 2/26/2026 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 2,460 | $1.2M | 2/26/2026 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,433 | $0 | 2/26/2026 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,703 | $862K | 2/26/2026 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,633 | $0 | 2/10/2026 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,306 | $644K | 2/10/2026 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 25,500 | $4.4M | 1/27/2026 | View on chart |
| ISRG | ▼ Sell | Open Market | 24,500 | $13.0M | 1/27/2026 | View on chart |
| ISRG | ▼ Sell | Open Market | 1,400 | $744K | 1/27/2026 | View on chart |
| ISRG | ▼ Sell | Open Market | 1,400 | $744K | 1/27/2026 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 25,500 | $3.6M | 12/1/2025 | View on chart |
| ISRG | ▼ Sell | Open Market | 22,806 | $13.0M | 12/1/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 36,000 | $3.9M | 10/24/2025 | View on chart |
| ISRG | ▼ Sell | Open Market | 28,800 | $15.8M | 10/24/2025 | View on chart |
| ISRG | ▼ Sell | Open Market | 1,400 | $765K | 10/24/2025 | View on chart |
| ISRG | ▼ Sell | Open Market | 1,400 | $765K | 10/24/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 36,000 | $2.9M | 8/29/2025 | View on chart |
| ISRG | ▼ Sell | Open Market | 29,360 | $13.9M | 8/29/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 7,893 | $469K | 7/28/2025 | View on chart |
| ISRG | ▼ Sell | Open Market | 7,893 | $3.9M | 7/28/2025 | View on chart |
| ISRG | ▼ Sell | Open Market | 1,400 | $693K | 7/28/2025 | View on chart |
| ISRG | ▼ Sell | Open Market | 1,400 | $693K | 7/28/2025 | View on chart |
| ISRG | ▼ Sell | Gift | 10,500 | $0 | 7/28/2025 | View on chart |
| ILMN | ▲ Buy | Grant | 3,780 | $0 | 5/21/2025 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,243 | $701K | 2/28/2025 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 6,213 | $3.5M | 2/28/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,506 | $0 | 2/28/2025 | View on chart |
| ISRG | ▲ Buy | Grant | 12,530 | $0 | 2/27/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,030 | $0 | 2/26/2025 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,503 | $862K | 2/26/2025 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 2,460 | $1.4M | 2/26/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 4,961 | $0 | 2/26/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,634 | $0 | 2/10/2025 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,055 | $615K | 2/10/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 25,200 | $1.5M | 10/30/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 18,151 | $9.3M | 10/30/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 3,720 | $1.9M | 10/30/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 3,720 | $1.9M | 10/30/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 25,200 | $1.4M | 7/30/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 23,388 | $10.4M | 7/30/2024 | View on chart |
| ISRG | ▼ Sell | Gift | 12,500 | $0 | 7/30/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 3,720 | $1.7M | 7/30/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 3,720 | $1.7M | 7/30/2024 | View on chart |
| ILMN | ▲ Buy | Grant | 2,622 | $0 | 5/16/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,864 | $0 | 2/29/2024 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,959 | $757K | 2/29/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,506 | $0 | 2/29/2024 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,271 | $491K | 2/29/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,030 | $0 | 2/26/2024 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,536 | $599K | 2/26/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,634 | $0 | 2/10/2024 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,335 | $518K | 2/10/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 33,750 | $1.7M | 1/29/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 2,480 | $929K | 1/29/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 2,480 | $929K | 1/29/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 24,325 | $9.1M | 1/29/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 33,750 | $1.7M | 10/26/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 27,385 | $7.1M | 10/26/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 2,480 | $674K | 10/24/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 2,480 | $674K | 10/24/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 2,480 | $808K | 7/31/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 2,480 | $808K | 7/31/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 67,500 | $2.9M | 7/28/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 50,314 | $16.4M | 7/28/2023 | View on chart |
| ISRG | ▼ Sell | Gift | 16,000 | $0 | 7/28/2023 | View on chart |
| ILMN | ▲ Buy | Grant | 1,532 | $0 | 5/26/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,864 | $0 | 2/28/2023 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,916 | $440K | 2/28/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,507 | $0 | 2/28/2023 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,243 | $285K | 2/28/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,030 | $0 | 2/26/2023 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,449 | $335K | 2/26/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,750 | $0 | 2/15/2023 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,308 | $320K | 2/15/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 67,500 | $4.3M | 10/21/2022 | View on chart |
| ISRG | ▼ Sell | Open Market | 44,203 | $9.3M | 10/21/2022 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 126,000 | $7.2M | 7/26/2022 | View on chart |
| ISRG | ▼ Sell | Open Market | 79,412 | $17.2M | 7/26/2022 | View on chart |
| ILMN | ▲ Buy | Grant | 1,232 | $0 | 5/26/2022 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,867 | $0 | 2/28/2022 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,918 | $557K | 2/28/2022 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,030 | $0 | 2/26/2022 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,503 | $441K | 2/26/2022 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 4,248 | $0 | 2/15/2022 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,595 | $461K | 2/15/2022 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,750 | $0 | 2/15/2022 | View on chart |
| ISRG | ▼ Sell | Tax Withholding | 1,860 | $538K | 2/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Intuitive Surgical Prepares for Q3 Earnings Amid Growth and Competition
Intuitive Surgical is approaching its Q3 earnings release, with analysts noting continued double‑digit revenue growth and expanding procedure volumes. At the same time, new robotic competitors are entering the market, prompting discussion of the company's current valuation multiples. The stock has shown strong price momentum, reflected in a relatively high RSI and recent touches near its 200‑day moving average.
Intuitive Surgical Prepares for Q3 Earnings Amid Growth and Competition. Intuitive Surgical is approaching its Q3 earnings release, with analysts noting continued double‑digit revenue growth and expanding procedure volumes. At the same time, new robotic competitors are entering the market, prompting discussion of the company's current valuation multiples. The stock has shown strong price momentum, reflected in a relatively high RSI and recent touches near its 200‑day moving average.